{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:42:08Z","timestamp":1791690128099,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005227","name":"Centers for Medicare and Medicaid Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018141","name":"Cerebrotech Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013410","name":"LivaNova Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","brainstimjrnl.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.brs.2024.03.016","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T06:48:00Z","timestamp":1712040480000},"page":"448-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6849-9416","authenticated-orcid":false,"given":"Charles R.","family":"Conway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-8801","authenticated-orcid":false,"given":"Scott T.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1107-4553","authenticated-orcid":false,"given":"Harold A.","family":"Sackeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5261-9659","authenticated-orcid":false,"given":"Walter","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Stedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Riva-Posse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Alva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Azfar","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Dunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Cichowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8263-1552","authenticated-orcid":false,"given":"Heather","family":"Luing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zajecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Nahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Mickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-0036","authenticated-orcid":false,"given":"Anita S.","family":"Kablinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Kriedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Bunker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chieh (Lisa)","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Shy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8747-3755","authenticated-orcid":false,"given":"Shannon","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Olin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.brs.2024.03.016_bib1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatr"},{"issue":"11","key":"10.1016\/j.brs.2024.03.016_bib2","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatr"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib3","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.brs.2024.03.016_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatr"},{"issue":"8","key":"10.1016\/j.brs.2024.03.016_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.euroneuro.2012.09.002","article-title":"Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder","volume":"23","author":"Amital","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib6","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11725","article-title":"Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a US commercial claims database","volume":"79","author":"Amos","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.brs.2024.03.016_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","article-title":"Treatment-resistant depression and suicidality","volume":"235","author":"Bergfeld","year":"2018","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.brs.2024.03.016_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12888-020-02935-z","article-title":"Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Psychiatr"},{"key":"10.1016\/j.brs.2024.03.016_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2020.02.023","article-title":"The identification, assessment and management of difficult-to-treat depression: an international consensus statement","volume":"267","author":"McAllister-Williams","year":"2020","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0004867418808585","article-title":"Difficult-to-treat depression: a clinical and research roadmap for when remission is elusive","volume":"53","author":"Rush","year":"2019","journal-title":"Aust N Z J Psychiatr"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamapsychiatry.2022.3860","article-title":"Association of treatment-resistant depression with patient outcomes and health care resource utilization in a population-wide study","volume":"80","author":"Lundberg","year":"2023","journal-title":"JAMA Psychiatr"},{"issue":"1","key":"10.1016\/j.brs.2024.03.016_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.brs.2024.03.016_bib13","article-title":"Definition of treatment-resistant depression in the Medicare population","author":"Gaynes","year":"2018","journal-title":"AHRQ Technology Assessments. Rockville (MD)"},{"issue":"8","key":"10.1016\/j.brs.2024.03.016_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamapsychiatry.2017.1670","article-title":"Modern electroconvulsive therapy: vastly improved yet greatly underused","volume":"74","author":"Sackeim","year":"2017","journal-title":"JAMA Psychiatr"},{"issue":"1","key":"10.1016\/j.brs.2024.03.016_bib15","first-page":"33","article-title":"Ketamine for treatment of mood disorders and suicidality: a narrative review of recent progress","volume":"34","author":"Kritzer","year":"2022","journal-title":"Ann Clin Psychiatr"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am J Psychiatr"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib17","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1192\/bjo.2023.5","article-title":"Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study","volume":"9","author":"Nygren","year":"2023","journal-title":"BJPsych Open"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis","volume":"30","author":"Heijnen","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.brs.2024.03.016_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104848","article-title":"The association between sample and treatment characteristics and the efficacy of repetitive transcranial magnetic stimulation in depression: a meta-analysis and meta-regression of sham-controlled trials","volume":"141","author":"Dalhuisen","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.brs.2024.03.016_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2020.08.005","article-title":"Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation","volume":"277","author":"Sackeim","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2024.03.016_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106066","article-title":"A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: a novel design for a novel treatment","volume":"95","author":"Conway","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.brs.2024.03.016_bib22","unstructured":"RECOVER. ClinicalTrials.gov Identifier: NCT03887715. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy\u00ae System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER). Study sponsored by LivaNova, PLC. US National Library of Medicine, First Posted: March 25, 2019. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03887715.2019."},{"key":"10.1016\/j.brs.2024.03.016_bib23","unstructured":"CMS. Guidance for the Public, Industry, and CMS Staff: Coverage with Evidence Development. US Centers for Medicare & Medicaid Services. Issued on 20 Nov 2014. https:\/\/www.cms.gov\/medicare-coverage-database\/view\/medicare-coverage-document.aspx?MCDId=27.2014."},{"key":"10.1016\/j.brs.2024.03.016_bib24","unstructured":"CMS. CMS National Coverage Determination: Vagus Nerve Stimulation (VNS) for Treatment Resistant Depression (TRD). US Centers for Medicare & Medicaid Services. Issued 04 September 2019. https:\/\/www.cms.gov\/medicare\/coverage\/evidence\/vagus-nerve-stimulation. 2019."},{"key":"10.1016\/j.brs.2024.03.016_bib25","series-title":"Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5); 2013. Washington, DC","year":"2013"},{"key":"10.1016\/j.brs.2024.03.016_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2194-7511-1-21","article-title":"Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (M.I.N.I.) module for the DSM-5 'With Mixed Features' specifier","volume":"1","author":"Hergueta","year":"2013","journal-title":"Int J Bipolar Disord"},{"issue":"Suppl 20","key":"10.1016\/j.brs.2024.03.016_bib27","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.brs.2024.03.016_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpsychires.2019.03.021","article-title":"The assessment of resistance to antidepressant treatment: rationale for the antidepressant treatment history form: Short form (ATHF-SF)","volume":"113","author":"Sackeim","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.brs.2024.03.016_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.brs.2024.03.016_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00004850-200211000-00003","article-title":"Relative sensitivity of the montgomery-asberg depression rating scale, the Hamilton depression rating scale and the clinical global impressions rating scale in antidepressant clinical trials","volume":"17","author":"Khan","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatr"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mpr.79","article-title":"The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms","volume":"9","author":"Rush","year":"2000","journal-title":"Int J Methods Psychiatr Res"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jpsychires.2013.01.019","article-title":"Psychometric properties of the Quick inventory of depressive symptomatology (QIDS-SR) in UK primary care","volume":"47","author":"Cameron","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.brs.2024.03.016_bib35","series-title":"Clinical global impressions. ECDEU assessment manual for psychopharmacology\u2014revised","first-page":"218","author":"Guy","year":"1976"},{"key":"10.1016\/j.brs.2024.03.016_bib36","series-title":"Handbook of psychiatric measures","article-title":"Clinical global impressions (CGI) scale, modified","author":"Guy","year":"2000"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib37","first-page":"e218","article-title":"The antidepressant effects of risperidone and olanzapine in bipolar disorder","volume":"11","author":"McIntyre","year":"2004","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.brs.2024.03.016_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.brs.2024.03.016_bib39","series-title":"Handbook of psychiatric measures","first-page":"540","article-title":"Young mania rating scale","author":"Young","year":"2000"},{"issue":"1","key":"10.1016\/j.brs.2024.03.016_bib40","first-page":"61","article-title":"[Bech-Rafaelsen Mania Scale and Young Mania Rating Scale--comparison of psychometric properties of the two instruments for rating a manic syndrome]","volume":"45","author":"Wciorka","year":"2011","journal-title":"Psychiatr Pol"},{"issue":"1","key":"10.1016\/j.brs.2024.03.016_bib41","first-page":"26","article-title":"Sheehan suicidality tracking scale (Sheehan-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder","volume":"6","author":"Coric","year":"2009","journal-title":"Psychiatry"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib42","first-page":"321","article-title":"Quality of life enjoyment and satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.brs.2024.03.016_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2018.08.052","article-title":"Toward a very brief quality of life enjoyment and Satisfaction Questionnaire","volume":"242","author":"Rush","year":"2019","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.brs.2024.03.016_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol: a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Pol"},{"key":"10.1016\/j.brs.2024.03.016_bib45","series-title":"Measuring health and disability: manual for WHO disability assessment Schedule (WHODAS 2.0)","year":"2012"},{"issue":"12","key":"10.1016\/j.brs.2024.03.016_bib46","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1176\/appi.ajp.2016.16020176","article-title":"Early improvement in work productivity predicts future clinical course in depressed outpatients: findings from the CO-med trial","volume":"173","author":"Jha","year":"2016","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.brs.2024.03.016_bib47","series-title":"Work productivity and activity impairment Questionnaire (WPAI)","year":"2022"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.brs.2024.03.016_bib49","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/archpsyc.1997.01830230023003","article-title":"Natural history of diagnostic interview Schedule\/DSM-IV major depression. The Baltimore Epidemiologic catchment area follow-up","volume":"54","author":"Eaton","year":"1997","journal-title":"Arch Gen Psychiatr"},{"issue":"11","key":"10.1016\/j.brs.2024.03.016_bib50","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.4088\/JCP.14l09462","article-title":"Clinical characteristics and management of treatment-resistant depression","volume":"76","author":"Conway","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4088\/JCP.v67n0501","article-title":"Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression","volume":"67","author":"Dunner","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.brs.2024.03.016_bib52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatr"},{"issue":"4","key":"10.1016\/j.brs.2024.03.016_bib53","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s11126-021-09930-x","article-title":"Prevalence and impact of treatment-resistant depression in Latin America: a prospective, observational study","volume":"92","author":"Soares","year":"2021","journal-title":"Psychiatr Q"},{"issue":"8","key":"10.1016\/j.brs.2024.03.016_bib54","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1017\/S0033291712001717","article-title":"Estimating remission from untreated major depression: a systematic review and meta-analysis","volume":"43","author":"Whiteford","year":"2013","journal-title":"Psychol Med"},{"issue":"3","key":"10.1016\/j.brs.2024.03.016_bib55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2008.01.006","article-title":"Serious life events among resistant and non-resistant MDD patients","volume":"110","author":"Amital","year":"2008","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4088\/JCP.13r08815","article-title":"Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis","volume":"75","author":"Gaynes","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.brs.2024.03.016_bib57","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/npp.2008.118","article-title":"Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial","volume":"34","author":"Lisanby","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib58","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.brs.2020.06.016","article-title":"The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode","volume":"13","author":"Sackeim","year":"2020","journal-title":"Brain Stimul"},{"key":"10.1016\/j.brs.2024.03.016_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jad.2019.03.028","article-title":"Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression","volume":"250","author":"Kim","year":"2019","journal-title":"J Affect Disord"},{"issue":"5","key":"10.1016\/j.brs.2024.03.016_bib60","article-title":"Reducing the burden of difficult-to-treat major depressive disorder: revisiting monoamine oxidase inhibitor therapy","volume":"15","author":"Culpepper","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"issue":"4","key":"10.1016\/j.brs.2024.03.016_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00131746-200407000-00005","article-title":"The role of monoamine oxidase inhibitors in current psychiatric practice","volume":"10","author":"Fiedorowicz","year":"2004","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"10.1016\/j.brs.2024.03.016_bib62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-021-00226-6","article-title":"Recent advances in transdermal drug delivery systems: a review","volume":"25","author":"Jeong","year":"2021","journal-title":"Biomater Res"},{"issue":"1\u20133","key":"10.1016\/j.brs.2024.03.016_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2007.04.024","article-title":"The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability","volume":"105","author":"Robinson","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2024.03.016_bib64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","article-title":"Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis","volume":"302","author":"Nunez","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2024.03.016_bib65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jad.2014.05.053","article-title":"A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression","volume":"168","author":"Nelson","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2024.03.016_bib66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2023.11.023","article-title":"Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: a systematic review and network meta-analysis","volume":"346","author":"Terao","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2024.03.016_bib67","series-title":"Manic-depressive illness: bipolar disorders and recurrent depression","author":"Goodwin","year":"2008"},{"issue":"4","key":"10.1016\/j.brs.2024.03.016_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10673220903129814","article-title":"Anticonvulsants in the treatment of major depressive disorder: an overview","volume":"17","author":"Vigo","year":"2009","journal-title":"Harv Rev Psychiatr"},{"issue":"9","key":"10.1016\/j.brs.2024.03.016_bib69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ijnp\/pyaa033","article-title":"Pharmacological augmentation in unipolar depression: a guide to the guidelines","volume":"23","author":"Taylor","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.brs.2024.03.016_bib70","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2017.16010034","article-title":"A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality","volume":"174","author":"Aaronson","year":"2017","journal-title":"Am J Psychiatr"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X24000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X24000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T02:16:49Z","timestamp":1744683409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X24000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1935861X24000524"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2024.03.016","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2024.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}